AI assistant
Citi Pharma Ltd. Director's Dealing 2025
71782_rns_2025-03-04_bf3b2741-3fa3-4ea8-b48f-ab903c9f47dc.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Citi Pharma Limited
March 4, 2025
The General Manager, Pakistan Stock Exchange Limited, Stock Exchange Building, Stock Exchange Road, Karachi
Subject: DISCLOSURE OF INTEREST BY DIRECTOR / CEO OR EXECUTIVES
Dear Sir,
With reference to the subject cited above, it is to inform you that Mr. Rizwan Ahmad, CEO/Director, has acquired 1.20 million shares of Citi Pharma Limited through settlement of Futures contract. This transaction was initiated through acquisition of 1.20 million shares in CPHL-February futures contract on 23rd January 2025. The details are as follows:
| (b} \,' Mit f ReI |
dr cate\$) |
Dat | :tIre | Rate | No. of hareB) |
Cunrulative ECutrruiative Percentage |
|---|---|---|---|---|---|---|
| iii;;=mlGEf-BMe Director |
CDC | 202541-22 | 88.44 | 44790000 | 19,SO |
miM Citi PhardHLimited – Care to Cure
